baber/WOPTO huggingface dataset:
Patent NZ-595347-A (NZ)
Title: Method for manufacturing amino acid liquid fertilizer using livestock blood and amino acid liquid fertilizer manufactured thereby
Inventor: OH JIN-YEOL
IPC: C05F1/00
Filed: 2009-09-17
Abstract: Discloses a method for manufacturing an amino acid fertilizer using livestock blood, the method comprising: (i) collection of livestock blood produced from a slaughterhouse and grinding the blood; (ii) adding a protease extracted from soybeans to the ground blood, putting the protease-added blood into a reactor which is maintained at about 50? to about 70?; (iii) inducing a reaction under for about 8 to about 15 hours, terminating the reaction when a pH of the 10 blood is about 7.5 to about 8.0, and cooling off the reactants for about 3 to about 4 hours; (iv) addition of additives comprising: urea, potash, ammonium phosphate dibasic, aqueous zinc, and EDTA to water at about 25? to about 80? in a separate mixing vessel and mixing the mixture completely to prepare an additive mixture solution; (iv) a step of filtering the blood prepared in (ii) using a 100 mesh filter and mixing the additive mixture solution prepared in the (iv) with the filtered blood Further disclosed is mixture ratio of additive components to filtered blood component.
Patent NZ-595570-A (NZ)
Title: Wholegrain instant pasta
Inventor: BATTAINI GIUSEPPE
IPC: A23L23/00
Filed: 2010-04-07
Abstract: 595570 Discloses a dry instant pasta comprising at least 50% wholegrain semolina, wherein the semolina particles have a size of less than 400 microns and contains the bran, the germ and the endosperm of the wheat in the same proportions as the intact wheat and wherein the pasta has a wall thickness of at most 0.6mm.
Patent NZ-595626-A (NZ)
Title: Wood and cell wall gene microarray
Inventor: BLOKSBERG LEONARD N
IPC: C07H21/00
Filed: 2006-12-06
Abstract: Disclosed is an isolated polynucleotide comprising a nucleic acid sequence, as defined in the specification. The specific polynucleotide is used in DNA constructs which in turn are used for producing transgenic plants.
Patent NZ-597202-A (NZ)
Title: Mattress with quilted zoned topper
Inventor: CARLITZ STUART
IPC: A47C27/00
Filed: 2009-11-02
Abstract: 597202 A quilted zoned topper and a mattress (10) are disclosed each comprising a quilted panel (13). The quilted panel (13) has a ticking material (22), a backing material (24), and a compressible support material (26) between the ticking (22) and backing (24) material. The ticking material (22), the support material (26) and the backing material (24) are all quilted together by a stitching pattern. The stitching pattern has an increased amount of stitching in a centre section (14) of the quilted panel than adjacent head and foot sections (18, 20) so that the support material pre-compresses in the centre section (14). The compressed region (14) defines a pocket and a memory foam insert (30) is provided in the pocket.
Patent NZ-597842-A (NZ)
Title: Cardboard container
Inventor: MARSHALL NEIL
IPC: B31B50/28
Filed: 2010-07-06
Abstract: Disclosed is a container, particularly a cup, having a base (3), a first sidewall (2) and a second sidewall (23). The first sidewall comprises at least a first circumferential shaping (21) directed inwardly and/or outwardly, which is compressed in its height extension. The second sidewall maintains the shaping in its compressed shape.
Patent NZ-599254-A (NZ)
Title: Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
Inventor: FRANK ROBERT
IPC: A61K31/44
Filed: 2008-04-15
Abstract: 599254 Disclosed are phenyl amide compounds of formula (I) where the variables are as disclosed in the specification. Also disclosed are process for preparing compounds of formula (I) and pharmaceutical compositions comprising a compound of formula (I). The compounds are useful for interacting with vanilloid receptor and treating diseases associated with vanilloid receptors 1 such as pain.
Patent NZ-599593-A (NZ)
Title: Weld-compatible interlocking playground tiles
Inventor: HARRIS PAUL
IPC: B29C65/34
Filed: 2012-04-26
Abstract: 599593 A moulded, connectable thermoplastics tile 100 for forming, when joined to a plurality of tiles having the same configuration by adjacent edges, a resilient playground surface, the tile 100 having a rectangular form in a horizontal plane (when in use), an upper surface including friction-enhancing surface patterns and openings into drainage apertures, an underneath surface including support means and exits from the drainage apertures, a thickness, and four edges. Structures directed to formation of secure inter-tile joints or seams of a playground surface comprise a spaced-apart series of extended, moulded lugs 102 along two adjoining edges, each lug having an origin along the edge and an underneath surface in the same plane as the underneath surface of the tile 100, each lug being extended in the horizontal plane, and along the underside of the remaining two adjoining edges of the tile 100, a spaced-apart series of inwardly horizontally extended, moulded receptacles 301, each receptacle 301 comprising a space capable of receiving the neck and head of any one laterally extended moulded lug of an adjoining tile 100. Each lug has a horizontally directed neck having a neck length between the origin of the neck and an enlarged head having two ears 211, 211', one ear extending horizontally sideways from each side of the head terminating the neck, and a neck thickness of about half of the tile thickness, so that a welding wire may be laid on to the lugs 102 used on tiles already connected by the lugs 102 and subsequently heated thereby causing fusion of the tiles. Each receptacle 301 has a depth between the underneath surface and toward the top surface equal to or greater than the thickness of the lug, a head-receiving space, and a neck-receiving space having a length longer than the neck length of the extended lug between the head-receiving space and the edge of the tile 100, so that, when two tiles are connected by means of the lugs 102, each receptacle 301 is capable of maintaining a controlled horizontal tension within the neck of the connected lug thereby maintaining adjacent edges in close contact.
Patent NZ-599826-A (NZ)
Title: Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
Inventor: HALTER ROBERT J
IPC: A61K31/505
Filed: 2010-10-12
Abstract: The disclosure relates to amino-pyrimidine compounds of formula (I) which selectively inhibit the kinase activities of TBK1 and/or IKK epsilon, wherein the variables shown if formula (I) are as defined in the specification. These compounds may be used in the treatment of inflammation, septic shock, Primary open Angle Glaucoma (POAG), RA, SLE, diseases associated with aberrant accumulation of cytosolic nucleic acids (including Sjogrens syndrome, Aicardi-Goutieres syndrome, subtypes of SLE, chilblain lupus, and RVCL), systemic sclerosis, myositis (including dermatomyositis and polymyositis), psoriasis, COPD, lBD, obesity, insulin resistance, NlDDM, metabolic syndrome and cancer, and complications associated with these diseases and disorders.
Patent NZ-600160-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: ANDERBERG JOSEPH
IPC: A61K39/395
Filed: 2010-11-05
Abstract: Disclosed is a method for evaluating renal status in a subject, comprising: performing one or more assays ex vivo, each assay being configured to detect one or more kidney injury markers present in a body fluid sample obtained previously from the subject, wherein at least one of said kidney injury markers is soluble transmembrane glycoprotein NMB; determining one or more assay result(s) each assay result comprising a measured level of the one or more kidney injury markers including soluble transmembrane glycoprotein NMB; and correlating the assay result(s) to the renal status of the subject, said correlating comprising comparing a measured concentration of the one or more kidney injury markers including soluble transmembrane glycoprotein NMB to a threshold concentration of the one or more kidney injury markers including soluble transmembrane glycoprotein NMB and assigning a likelihood or non-likelihood of an event occurring or having occurred when the measured concentration varies from the threshold.
Patent NZ-601283-A (NZ)
Title: Cell management method and a corresponding controller thereof in a radio communication network
Inventor: TANNEAU LANNIG
IPC: H04W84/08
Filed: 2011-02-25
Abstract: Disclosed is a method of managing a cell (104) of a radio telecommunication network (102). The cell (104) has a site controller (100) intended to control, via a packet network (114), a plurality of transmitters (1081,1082,1083 ; 1101, 1102, 1103 ; 1121, 1122 , 1123) distributed over different sites (1, 2, 3) of the cell (104). The transmitters (1081,1082,1083 ; 1101, 1102, 1103 ; 1121, 1122 , 1123) of these different sites (1, 2, 3) transmit a certain channel (10) within the transmission channels (10, 20, 30) , such that this certain channel (10) is a control channel dedicated to the transmission of signals relative to the operation of the cell (104). The signals include general operating signals and specific operating signals. A request with general operating signals is transmitted from the site controller (100) to at least one transmitter (1082) selected by the site controller (100) to control storage of general operating signals in the selected transmitter (1082). A transmission of the general operating signals addressed to all of the terminals (105) present in the cell (104) is handled over the control channel (10) in case of failure of the site controller (100) and/or of the packet network (114). Migration of a terminal to another cell then occurs only if a specific operation is required by the terminal.
Patent NZ-601969-A (NZ)
Title: Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
Inventor: LAI JIN-WANG
IPC: A61K9/16
Filed: 2005-10-13
Abstract: ABSTRACT - 601969 The disclosure relates to a taste-masked multiparticulate pharmaceutical composition comprising: (a) a drug-containing core particle, and (b) a solvent-coacervated membrane on said drug-containing core particle comprising a combination of a water-insoluble polymer and a gastrosoluble, organic or inorganic pore-former at a ratio ranging from about 95/5 to about 50/050, said membrane having a thickness of from about 5% to about 50% by weight based on the weight of the coated particle and an average particle size of not more than about 400μm, wherein said composition has the following properties: (1) said composition has acceptable taste-masking when the composition is placed in the oral cavity for at least about 60 seconds; and (2) said composition releases not less than about 60% of the dose in 30 min when tested for dissolution using United States Pharmacopoeia Apparatus ! (Baskets @ 100 rpm in 900 mL of pH 1.2 buffer), and wherein said water insoluble polymer is selected from the group consisting of ethylcellulose, cellulose acetate, cellulose acetate butyrate, polyvinyl acetate, neutral methacrylic ester copolymer, ammonio-methacrylate copolymers and mixtures thereof, and said gastrosoluble organic or inorganic pore-former is selected from the group consisting of calcium carbonate, calcium phosphate, calcium saccharide, calcium succinate, calcium tartrate, ferric acetate, ferric hydroxide, ferric phosphate, magnesium carbonate, magnesium citrate, magnesium hydroxide, magnesium phosphate, and mixtures thereof. Also disclosed is a method of manufacturing the taste-masked multi-particulate composition comprising the above features.
Patent NZ-624113-A (NZ)
Title: An electrically operated aerosol generating system having aerosol production control
Inventor: FLICK JEAN-MARC
IPC: A24F40/51
Filed: 2012-10-25
Abstract: An electrically operated aerosol generating device (100) is disclosed. The device comprises at least one heating element (119) for heating an aerosol-forming substrate, a power source (107) for providing power to the heating element (119), and electric circuitry (109) for controlling the supply of power to the heating element. The electric circuitry (109) includes a sensor for detecting air flow past the aerosol generating element. The electric circuitry (109) is arranged to determine a first parameter related to change in flow rate of the air flow, compare the first parameter to a threshold value, and subsequently reduce or suspend the supply of power to the heating element (119). The first parameter is derived from a combination of second and third parameters, wherein the second parameter relates to an air flow rate through the device, and the third parameter relates to one, or a combination of, temperature , power supplied to the heating element (119), a maximum detected flow rate, or a rate of change of flow rate. A method of controlling aerosol production in an aerosol generating device is also disclosed.
Patent NZ-631671-A (NZ)
Title: A skiing accessory
Inventor: DARCY STEVEN
IPC: B63B35/85
Filed: 2014-01-22
Abstract: A skiing accessory comprises a support structure (212), a mounting arrangement (14) and a lift member (112). The support structure is configured to support a user relative to a body of water. The mounting arrangement is configured to connect the support structure to a ski boom (16). The lift member is arranged on the support structure and configured to engage the body of water such that the support structure is raised or lifted, relative to the body of water, by the lift member as the accessory is towed. The mounting arrangement permits the support structure to be pivotally connected to the ski boom about an axis that is generally parallel to the ski boom.
Patent NZ-702176-A (NZ)
Title: Railway freight car bogie and railway freight car
Inventor: XU SHANCHAO
IPC: B61F5/50
Filed: 2013-05-22
Abstract: A railway freight car bogie, comprising two side frames (101) arranged in parallel and two connecting rods (104); after the connecting rods (104) cross each other, the two ends are respectively connected to the two side frames (101); an installation positioning face is disposed below a triangular hole in the side frame (101); a conical column positioning hole is disposed on the installation positioning face; a retaining shoulder (102) is disposed on the installation positioning face and on the outer side of the conical column positioning hole; a conical column (105) is inserted in the conical column positioning hole; the gap (103) between the conical column (105) and the retaining shoulder (102) is welded by filling. Also disclosed is a railway freight car having the railway freight car bogie.
Patent NZ-702851-A (NZ)
Title: New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
Inventor: DAVIDSON JAMES EDWARD PAUL
IPC: C07D495/04
Filed: 2014-12-10
Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description, processes for their preparation, pharmaceutical compositions containing them and their use as pro-apoptotic agents.
Patent NZ-703888-A (NZ)
Title: Methods of generating natural killer cells
Inventor: HARIRI ROBERT J
IPC: A61K35/12
Filed: 2011-07-13
Abstract: Disclosed is a method of producing a population of activated natural killer (NK) cells, comprising: (a) seeding a population of CD34+ hematopoietic stem or progenitor cells in a first medium comprising interleukin-15 (IL-15) and, optionally, one or more of stem cell factor (SCF) and interleukin-7 (IL-7), wherein said hematopoietic stem or progenitor cells have been isolated from a source of such cells and have not been cultured, and wherein said IL-15 and optional SCF and IL-7 are not comprised within an undefined component of said medium, such that the population expands, and a plurality of hematopoietic stem or progenitor cells within said population of hematopoietic stem or progenitor cells differentiate into NK cells during said expanding; and (b) next expanding the NK cells from step (a) in a second medium comprising interleukin-2 (IL-2), to produce a population of activated NK cells. Also disclosed is a population of activated natural killer cells produced by said method. Further disclosed is the use of a population of activated natural killer cells produced by said method in the manufacture of a composition for treating an individual with cancer.
Patent NZ-710977-A (NZ)
Title: Fluorometer with multiple detection channels
Inventor: CHRISTENSEN WILLIAM
IPC: G01N21/85
Filed: 2014-03-06
Abstract: An optical sensor may have multiple detection channels to detect different characteristics of a fluid. For example, an optical sensor used in industrial cleaning and sanitizing applications may have multiple detection channels to detect when a system is both clean and properly sanitized. In one example, an optical sensor includes an optical emitter that directs light into a fluid, a first optical detector that detects light transmitted through the fluid, a second optical detector that detects light scattered by the fluid, and a third optical detector that detects fluorescent emissions emitted by the fluid. The optical emitter and optical detectors can be positioned around an optical analysis area. Depending on the application, the optical emitter may be positioned to direct light adjacent a wall of the optical analysis area rather than at a center of the optical analysis area, which may increase the strength of signal on the detection channels.
Patent NZ-717269-A (NZ)
Title: Providing command queuing in embedded memories
Inventor: SHACHAM ASSAF
IPC: G06F13/42
Filed: 2014-09-08
Abstract: Command queuing allows for more efficient use of the bus in mobile devices. However, given that embedded Multi-Media Card (eMMC) has not contemplated command queueing, there is a need to define how a host may learn of the status of tasks in the queue at a device. Providing command queuing in embedded memories is provided. In particular, aspects disclosed herein relate to a process through which a status of the queue is communicated to a host from a device. Aspects of the present disclosure use the command structure of the embedded Multi-Media Card (eMMC) standard, such that the host may determine a state of the queue in the device proximate a known end of an in-progress data transfer. In this manner, the host can select a task to commence after completion of a current data transfer while the current data transfer is still ongoing.
Patent NZ-728260-A (NZ)
Title: Device and technique for generating power from moving water
Inventor: ALBERT MAGDI ISKANDER YOUSSEF
IPC: F03B13/12
Filed: 2017-01-12
Abstract: A water wheel turbine for generating power from a water current in a body of water, comprising multiple waterwheels. The wheels have paddles, which have wings that channel the water current to a successive row of paddles on an adjacent wheel. The wings of the water wheels work as self-barrier and director of the water current, reducing turbulence flow within the device. The gaps between the wings with the adjacent rear paddle do not create a significant resistance in the water current in front of the device compared with other waterwheel turbines. The device may operate in a body of water where it can be fixed or floating over a flume rigid foundation or over barrage foundation.
Patent NZ-731847-A (NZ)
Title: Heterocyclic derivatives and use thereof
Inventor: PARK CHAN HEE
IPC: A61P35/00
Filed: 2015-11-30
Abstract: A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein, is provided.
Patent NZ-734560-A (NZ)
Title: Computerised system and method to facilitate the transfer and exploitation of rights in a portion of the future work
Inventor: KLAUDIUSZ ZBYGNIEW DRULIK
IPC: G06Q30/06
Filed: 2014-09-12
Abstract: Disclosed is a processing system and method for facilitating sale of rights to portion of a work being produced, for example a product placement spot in a movie being filmed. The system is configured to receive data indicative of a depiction of the work, such as a scene of the movie, and selection of a portion of the work, such as a product appearing in the movie scene, where the rights associated with the portion are for sale. The system allows a bidding party to search a database to identify portions of work that meet search criteria and bid on the rights to the portions (i.e. the right to place their product in the product placement spot of the movie scene). If the bid is accepted, a record of the transfer of rights to the bidding party is recorded.
Patent NZ-743260-A (NZ)
Title: Bipiperidine-2-one compounds for the preparation of pyrimidinyl tyrosine kinase inhibitors
Inventor: HOPKINS BRIAN T
IPC: C07D401/04
Filed: 2013-06-07
Abstract: The present invention provides compounds of formula I’ which are synthetic intermediates for compounds that are useful as inhibitors of Bruton’s tyrosine kinase.
Patent NZ-747854-A (NZ)
Title: Egfr inhibitor compounds
Inventor: BUNKER KEVIN
IPC: C07D403/04
Filed: 2017-05-24
Abstract: Disclosed herein are nitrogen-containing bicyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.
Patent NZ-749729-A (NZ)
Title: Non-dairy formulae
Inventor: KESLER URIEL
IPC: A23L33/10
Filed: 2014-02-12
Abstract: The present invention is directed to a process for the preparation of a dry non-dairy whole balance nutrition composition comprising: (i) an almond component with reduced phytic acid content; and (ii) at least one single non-dairy component comprising all essential amino acids being at least one type of grain that has been pre-hydrolized and/or pre-gelatinized; said process comprising the steps of: (a) mixing almond with at least one non-dairy component; (b) adding water to the mixture obtained in step (a) to obtain a suspension; (c) drying the suspension obtained in step (b), thereby obtaining a dry non-dairy whole balance nutrition composition; wherein prior to step (a) said almond is treated for lowering the levels of phytic acid and said at least one non-dairy component is hydrolized and/or gelatinized; thereby said dry non-dairy whole balance nutrition composition is obtained.
Patent PT-100615-A (PT)
Inventor: GRUETZMACHER GORDON D
IPC: A23L1/308
Filed: 1992-06-23
Abstract: A tetraester of sorbitol anhydride derived from a mixture of fatty acids, wherein the fatty acid groups of said tetraester are obtained from oils selected from the group consisting of non-hydrogenated, partially hydrogenated, or hydrogenated oils selected from the group consisting of soybean oil, safflower oil, sunflower oil, sesame oil, peanut oil, corn oil, olive oil, rice bran oil, canola oil, rapeseed oil, shea nut oil, babassu nut oil, coconut oil, palm kernel oil, cottonseed oil, and palm oil; tallow and lard; and mixtures thereof.
Patent PT-101087-A (PT)
Inventor: MACOR JOHN EUGENE
IPC: A61K31/53
Filed: 1992-11-23
Abstract: PCT No. PCT/US92/08306 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Oct. 6, 1992 PCT Pub. No. WO93/11106 PCT Pub. Date Jun. 10, 1993Compounds of the formula    <IMAGE>  I  wherein Z is   <IMAGE>   or   <IMAGE>   R1 is   <IMAGE> re each independently C, N, O, or S; wherein the remaining variables are defined in the specification, and the pharmaceutically acceptable salts thereof. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.